Arcadia Investment Management Lowered By $658,540 Its Citrix Sys (CTXS) Position; Aquinox Pharmaceuticals (AQXP) Shorts Increased By 4.84%

February 21, 2018 - By Marie Mckinney

Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) had an increase of 4.84% in short interest. AQXP’s SI was 275,100 shares in February as released by FINRA. Its up 4.84% from 262,400 shares previously. With 107,200 avg volume, 3 days are for Aquinox Pharmaceuticals Inc (NASDAQ:AQXP)’s short sellers to cover AQXP’s short positions. The SI to Aquinox Pharmaceuticals Inc’s float is 2.21%. The stock decreased 1.16% or $0.17 during the last trading session, reaching $14.45. About 139,451 shares traded or 15.32% up from the average. Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) has risen 122.35% since February 21, 2017 and is uptrending. It has outperformed by 105.65% the S&P500.

Arcadia Investment Management Corp decreased Citrix Sys Inc (CTXS) stake by 36.01% reported in 2017Q3 SEC filing. Arcadia Investment Management Corp sold 8,665 shares as Citrix Sys Inc (CTXS)’s stock rose 2.84%. The Arcadia Investment Management Corp holds 15,400 shares with $1.18 million value, down from 24,065 last quarter. Citrix Sys Inc now has $12.50B valuation. The stock increased 0.62% or $0.57 during the last trading session, reaching $91.78. About 2.37M shares traded or 50.90% up from the average. Citrix Systems, Inc. (NASDAQ:CTXS) has risen 26.42% since February 21, 2017 and is uptrending. It has outperformed by 9.72% the S&P500.




Among 6 analysts covering Aquinox Pharma (NASDAQ:AQXP), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Aquinox Pharma had 16 analyst reports since September 11, 2015 according to SRatingsIntel. As per Tuesday, October 6, the company rating was initiated by Guggenheim. Canaccord Genuity maintained the shares of AQXP in report on Tuesday, December 19 with “Buy” rating. The firm has “Buy” rating given on Sunday, February 11 by Cantor Fitzgerald. As per Friday, August 5, the company rating was maintained by Jefferies. The stock of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) earned “Outperform” rating by Leerink Swann on Monday, September 21. The firm has “Buy” rating given on Friday, October 23 by Needham. Canaccord Genuity maintained the stock with “Buy” rating in Tuesday, August 8 report. The rating was maintained by Canaccord Genuity with “Buy” on Monday, November 20. Canaccord Genuity maintained Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) rating on Monday, December 11. Canaccord Genuity has “Buy” rating and $22.0 target. As per Friday, September 11, the company rating was maintained by Canaccord Genuity.

Aquinox Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. The company has market cap of $339.07 million. The firm primarily focuses on anti-inflammatory product candidates targeting SH2-containing inositol-5Â’-phosphatase 1 enzyme, a key regulator of a cellular signaling pathway in immune cells. It currently has negative earnings. The Company’s lead product candidate is AQX-1125, a small molecule activator of SHIP1 that is in Phase III clinical trials for treatment in interstitial cystitis/bladder pain syndrome, a chronic inflammatory disease of the bladder.

Analysts await Citrix Systems, Inc. (NASDAQ:CTXS) to report earnings on April, 25. They expect $0.84 earnings per share, down 1.18% or $0.01 from last year’s $0.85 per share. CTXS’s profit will be $114.37 million for 27.32 P/E if the $0.84 EPS becomes a reality. After $1.47 actual earnings per share reported by Citrix Systems, Inc. for the previous quarter, Wall Street now forecasts -42.86% negative EPS growth.

Among 25 analysts covering Citrix Systems Inc. (NASDAQ:CTXS), 12 have Buy rating, 3 Sell and 10 Hold. Therefore 48% are positive. Citrix Systems Inc. had 84 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Citrix Systems, Inc. (NASDAQ:CTXS) earned “Buy” rating by Robert W. Baird on Thursday, January 18. The firm has “Buy” rating given on Friday, September 8 by Cowen & Co. The stock of Citrix Systems, Inc. (NASDAQ:CTXS) has “Sell” rating given on Monday, October 3 by UBS. The stock of Citrix Systems, Inc. (NASDAQ:CTXS) earned “Underweight” rating by Morgan Stanley on Thursday, February 1. The stock has “Outperform” rating by Cowen & Co on Thursday, April 21. The firm earned “Hold” rating on Thursday, October 26 by Stifel Nicolaus. The firm has “Underweight” rating by Morgan Stanley given on Wednesday, July 27. The company was maintained on Thursday, August 31 by Robert W. Baird. Jefferies maintained Citrix Systems, Inc. (NASDAQ:CTXS) on Thursday, October 26 with “Sell” rating. The stock of Citrix Systems, Inc. (NASDAQ:CTXS) earned “Sell” rating by Jefferies on Thursday, October 19.

Investors sentiment is 0.89 in Q3 2017. Its the same as in 2017Q2. It has no change, as 40 investors sold CTXS shares while 171 reduced holdings. only 44 funds opened positions while 144 raised stakes. 130.86 million shares or 0.86% less from 132.01 million shares in 2017Q2 were reported. Hudson Valley Invest Advsrs Adv owns 13,550 shares for 0.27% of their portfolio. 476 are owned by Cornerstone. Nomura Asset Commerce Ltd stated it has 0.02% of its portfolio in Citrix Systems, Inc. (NASDAQ:CTXS). Jnba Advsr has invested 0% in Citrix Systems, Inc. (NASDAQ:CTXS). Acadian Asset Mgmt Ltd owns 34,019 shares. The California-based Hanson Mcclain has invested 0% in Citrix Systems, Inc. (NASDAQ:CTXS). Joel Isaacson And Com Ltd Llc holds 0.14% in Citrix Systems, Inc. (NASDAQ:CTXS) or 10,000 shares. Rdl Financial Inc holds 1.53% of its portfolio in Citrix Systems, Inc. (NASDAQ:CTXS) for 27,022 shares. Blair William And Co Il reported 0% of its portfolio in Citrix Systems, Inc. (NASDAQ:CTXS). Franklin Inc accumulated 22,805 shares. Blackrock stated it has 9.61 million shares or 0.04% of all its holdings. Colony Group Incorporated Limited Liability Co invested 0.02% of its portfolio in Citrix Systems, Inc. (NASDAQ:CTXS). 405,042 are held by Glenmede Na. Coldstream Capital Management reported 0.03% of its portfolio in Citrix Systems, Inc. (NASDAQ:CTXS). Idaho-based Caprock Gru Incorporated has invested 0.08% in Citrix Systems, Inc. (NASDAQ:CTXS).

Arcadia Investment Management Corp increased Ishares Inc (EEMA) stake by 18,345 shares to 18,970 valued at $1.32 million in 2017Q3. It also upped Schwab Strategic Tr (SCHD) stake by 39,539 shares and now owns 41,985 shares. Abbvie Inc (NYSE:ABBV) was raised too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.